Literature DB >> 17559026

Enuresis persisting into adulthood.

Pejman Shadpour1, Masoud Shiehmorteza.   

Abstract

INTRODUCTION: Nocturnal enuresis is a very common finding in children to the extent that many families and caregivers, alike, may dismiss it as a developmental stage rather than a disease. Persistence of nocturnal enuresis into adulthood, however, has received little discussion and is surrounded by fallacies.
MATERIALS AND METHODS: All existing literature cited in PubMed between 1970 and 2005 were reviewed using the search entries "nocturnal enuresis AND adult*". RESULT: Of the 220 papers reviewed, enuresis persisting into adulthood was covered in only 87. Those aspects pertinent to this subset of patients were placed in focus.
CONCLUSION: In contrast to the numerous researches on childhood enuresis, persistent adulthood enuresis is an under discussed subject, distinct in a few aspects of its etiology and management described herein.

Entities:  

Year:  2006        PMID: 17559026

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  4 in total

1.  Lifetime prevalence and incidence of parasomnias in a population of young adult Nigerians.

Authors:  O S A Oluwole
Journal:  J Neurol       Date:  2010-02-09       Impact factor: 4.849

Review 2.  Pathogenesis and brain functional imaging in nocturnal enuresis: A review.

Authors:  Jiawen Dang; Zhanghua Tang
Journal:  Exp Biol Med (Maywood)       Date:  2021-03-09

3.  A nationwide epidemiological study of nocturnal enuresis in Korean adolescents and adults: population based cross sectional study.

Authors:  Minki Baek; Kwanjin Park; Hahn-Ey Lee; Ju Hyung Kang; Hong Jin Suh; Ji Hong Kim; Sang Don Lee; Ki Soo Pai; Sang Won Han; Yong Hoon Park; Kyung Do Kim
Journal:  J Korean Med Sci       Date:  2013-07-03       Impact factor: 2.153

4.  Melatonin's Effect on the Efficacy of Desmopressin in the Treatment of Enuresis.

Authors:  Pietro Ferrara; Annamaria Sbordone; Costanza Cutrona; Francesca Ianniello; Chiara Guadagno; Giacomo Perrone; Antonio Chiaretti; Alberto Verrotti; Vincenzo Di Lazzaro
Journal:  Int Neurourol J       Date:  2016-09-23       Impact factor: 2.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.